Clinical pharmacology of oral antidiabetic agents (second of two parts).
D000284:Administration, Oral; D002318:Cardiovascular Diseases / Q000401:mortality; D002747:Chlorpropamide / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D005951:Glucose Tolerance Test; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000187:drug effects; D010629:Phenformin / Q000009:adverse effects; D014044:Tolbutamide / Q000009:adverse effects; D014869:Water Intoxication / Q000139:chemically induced
D007004:Hypoglycemic Agents; D014044:Tolbutamide; D010629:Phenformin; D002747:Chlorpropamide